A temporary discontinuation (drug holiday) of high-dose antiresorptive (AR) agents has
been proposed to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ) …

The aim was to evaluate the knowledge about bisphosphonate-related osteonecrosis of the
jaws (BRONJ). A bibliographic search in Medline, PubMed and the Cochrane Register of …

The use of bisphosphonate drugs has been popularised in the late 20th century for the
management of many conditions associated with abnormalities of bone turnover, particularly …

There has been an exponential rise in the literature of osteonecrosis and its complications in
patients taking bisphosphonate drugs. Despite this increase, there is little evidence-based …

Background: Osteonecrosis of the jaw (ONJ) is a condition affecting patients exposed to
medications used to treat benign and malignant conditions of bone tissue. Many studies …

Background: Antiresorptive and antiangiogenic medications can cause a serious adverse
effect known as medication-related osteonecrosis of the jaw (MRONJ). In recent years, a …

Bisphosphonate osteonecrosis (BON) is a relatively recent adverse drug event that affects
the oral cavity almost exclusively. It has been reported in individuals with metastatic breast …

Introduction: Opinions differ regarding the combined use of local anaesthesia (LA) and
general anaesthesia (GA) in oral surgery procedures. The aim of this study was to evaluate …

In 2003, a case of osteonecrosis of the jaw related with medicine was documented for the
first time. In the past, osteonecrosis of the jaw was thought to be caused by intravenous and …

Osteoradionecrosis is one of the most severe complications from radiotherapy used for
treatment of head and neck cancer. It is a disease in which irradiated bone become necrotic …